Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA cream vs Mometasone Furoate cream in eczema
CTR20192503Phase 3Completed
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of medroxyprogesterone acetate in atopic dermatitis (AD), neurodermatitis, contact dermatitis, dyshidrosis, discoid eczema, sponsored by Tianjin Institute of Pharmaceutical Research. Started Dec 2019; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
atopic dermatitis (AD)neurodermatitiscontact dermatitisdyshidrosisdiscoid eczema
Beyond the preview
Go deeper on CTR20192503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192503.